Back to results
US 2026/0232871 A1Published application
Coronary Artery Bypass Graft
AssigneeVascudyne, Inc.
InventorZeeshan Syedain
Life of this patent
Estimating the term…
Abstract
The present invention is a coronary artery bypass graft (CABG) formed from a constructed tissue that can be implanted.
Claims16
An implant suitable for use in humans comprising a coronary artery bypass conduit engineered or constructed from tissue formed using a composition comprising an extracellular matrix (ECM)-producing cell, thrombin, and fibrinogen;
- wherein said tissue endothelializes.
Dependencies are inferred from the claim text.